Prescription RequiredEverolimus 5 mg is a targeted anticancer medicine used to treat certain types of advanced cancers, including breast cancer, kidney cancer, neuroendocrine tumours, and other approved conditions. It works by blocking a protein called mTOR, which helps cancer cells grow and divide. By slowing tumour growth, Everolimus helps manage the disease and improve treatment outcomes.
| Generic name | Everolimus |
| Strength | 5 mg |
| Manufacturer | Glenmark |
| Package size | 10 Tablets |
| Used for | Breast cancer, kidney cancer, neuroendocrine tumours |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Everolimus is an mTOR (mammalian target of rapamycin) inhibitor. It blocks the mTOR protein, which is involved in cancer cell growth, division, and blood vessel formation. This slows the growth and spread of cancer cells and helps control tumour progression.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
